121 related articles for article (PubMed ID: 6369051)
1. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results].
Gastpar H
Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051
[TBL] [Abstract][Full Text] [Related]
2. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
Ambrus JL; Ambrus CM; Gastpar H; Williams P
J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
[TBL] [Abstract][Full Text] [Related]
3. Studies on platelet aggregation in vivo. VI. Effect of a pyrimido-pyrimidine derivative [RA233] on tumor cell metastasis.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1978; 9(2):183-6. PubMed ID: 276567
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations.
Gastpar H; Ambrus JL; Ambrus CM
J Med; 1981; 12(1):15-33. PubMed ID: 6943264
[No Abstract] [Full Text] [Related]
5. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors.
Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J
Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804
[TBL] [Abstract][Full Text] [Related]
6. Effect of phosphodiesterase inhibitors on platelet aggregation and tumor metastasis.
Ambrus JL; Ambrus CM; Gastpar H
Ric Clin Lab; 1981; 11 Suppl 1():197-207. PubMed ID: 6324323
[TBL] [Abstract][Full Text] [Related]
7. Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.
Gastpar H
J Med; 1977; 8(2):103-14. PubMed ID: 268396
[TBL] [Abstract][Full Text] [Related]
8. Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis.
Gordon S; Witul M; Cohen H; Sciandra J; Williams P; Gastpar H; Murphy GP; Ambrus JL
J Med; 1979; 10(6):435-43. PubMed ID: 233697
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic effect of the pyrimido-pyrimidine derivative: RA 233.
Biddle W; Montagna RA; Leong SS; Horoszewicz J; Gastpar H; Ambrus JL
Pathol Biol (Paris); 1984 Jan; 32(1):9-13. PubMed ID: 6701010
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
Ambrus JL; Ambrus CM; Gastpar H
Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
[No Abstract] [Full Text] [Related]
11. Antimetastatic action of RX-RA 69, a new potent PDE-inhibitor in the Lewis lung carcinoma of the mouse.
Lichtner R; Haarmann W
Prog Clin Biol Res; 1982; 89():131-41. PubMed ID: 6287486
[TBL] [Abstract][Full Text] [Related]
12. Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.
Merriman RL; Shackelford KA; Tanzer LR; Campbell JB; Bemis KG; Matsumoto K
Cancer Res; 1989 Aug; 49(16):4509-16. PubMed ID: 2743339
[TBL] [Abstract][Full Text] [Related]
13. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
Gastpar H; Ambrus JL; Ambrus CM
Prog Clin Biol Res; 1982; 89():63-82. PubMed ID: 7111310
[TBL] [Abstract][Full Text] [Related]
14. Study of platelet aggregation in vivo: IV Effect of pyrimido-pyrimidine derivatives.
Ambrus JL; Ambrus CM; Gastpar H; Thurber L; Miller R; Fretwell B; Lane KP
J Med; 1977; 8(5):287-94. PubMed ID: 412904
[TBL] [Abstract][Full Text] [Related]
15. Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells.
Gastpar H; Ambrus J; Thurber LE
J Med; 1977; 8(1):53-6. PubMed ID: 267156
[TBL] [Abstract][Full Text] [Related]
16. Hemorrheologic effects of pyrimido-pyrimidine derivatives.
Ambrus JL; Stadler I; Kulaylat M; Koreshi A; Akhtar S
J Med; 1996; 27(1-2):21-32. PubMed ID: 8863175
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic and antitumor effect of platelet aggregation inhibitors.
Ambrus JL; Ambrus CM; Gastpar H; Huberman E; Montagna R; Biddle W; Leong S; Horoszewicz J
Prog Clin Biol Res; 1982; 89():97-111. PubMed ID: 7111312
[No Abstract] [Full Text] [Related]
18. Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol, on platelet and vascular cyclooxygenase activity.
De La Cruz JP; Ortega G; Sánchez de la Cuesta F
Biochem Pharmacol; 1994 Jan; 47(2):209-15. PubMed ID: 8304965
[TBL] [Abstract][Full Text] [Related]
19. The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.
De La Cruz JP; Moreno A; Mérida F; García Campos J; Sánchez de la Cuesta F
Thromb Res; 1996 Feb; 81(3):327-37. PubMed ID: 8928090
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of compound RA233 and bencyclane on platelet functions--with special reference to the effect on C-AMP metabolism.
Ryo R
Nihon Ketsueki Gakkai Zasshi; 1976 Feb; 39(1):97-108. PubMed ID: 183446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
